Interleukin-33 and Osteoprotegerin Levels in Gingival Crevicular Fluid and Saliva in Chronic Periodontitis and Their Correlation to Diabetes Mellitus: A Cross-Sectional Study by Tarrad, Nayroz et al.
Perio J – Original Article                                          2(1):1-9 doi: 10.26810/perioj.2018.a1                    2018
 
1 ©2018 The Authors                                                                                     www.perioj.com 
 
Interleukin-33 and Osteoprotegerin 
Levels in Gingival Crevicular Fluid and 
Saliva in Chronic Periodontitis and Their 
Correlation to Diabetes Mellitus: A 
Cross-Sectional Study 
Nayroz Tarrad,A Maha Abdelkawy,B Olfat Shaker C 
A Lecturer, Department of Oral Diagnosis, Oral Medicine, and 
Periodontology, Faculty of Dentistry, Fayoum University. 
 
B Lecturer, Department of Oral Diagnosis, Oral Medicine, and 
Periodontology, Faculty of Dentistry, Beni-Suef University. 
 
 
 
 
 
C Professor, Department of Biochemistry, Faculty of Medicine,  
Cairo University. 
 
Abstract 
Background: This study investigates the presence of interleukin (IL)-33 and osteoprotegerin (OPG) in 
saliva and gingival crevicular fluid (GCF) samples of patients with chronic periodontitis and whether or 
not they are correlated with diabetes mellitus. Methods: Sixty subjects were included in this study: 20 
chronic periodontitis patients (CP), 20 diabetic chronic periodontitis patients (CPDM) and 20 systemically 
and periodontally healthy subjects. GCF and saliva samples were collected from all participants. Enzyme 
linked immunosorbent assay (ELISA) kits were used for assaying IL-33 and OPG levels. Analysis of 
variance was used to compare means of the CP and CP-DM groups with the control. Correlation analyses 
were performed to find the value of Spearman's correlation. A receiver operating characteristic (ROC) 
curve was constructed to determine the cut-off values of the markers to differentiate between the groups. 
Areas under the ROC curve (AUCs) were compared using z-statistic. Results: IL-33, in both GCF and 
saliva, was significantly higher in the CP and CP-DM groups compared to the control, and significantly 
higher in the CP-DM group compared to the CP group in saliva. On the other hand, the level of OPG in 
GCF and saliva was significantly lower in the CP and CP-DM groups compared to the control, but was of 
no significance when comparing the CP-DM and CP groups. Conclusion: IL-33 seems to play a role in the 
pathogenesis of periodontal disease, while OPG may have a protective function. Diabetes may affect 
and influence the expression of IL-33. Thus, they could be utilized as diagnostic biomarkers for chronic 
periodontitis either in saliva or GCF. 
Keywords: Interleukin-33, osteoprotegerin, diabetes mellitus, chronic periodontitis, gingival crevicular 
fluid, saliva 
Introduction 
Periodontal diseases, which arise from the 
complicated interaction between bacterial insult 
and the host inflammatory-immune response 
against this insult, are governed by a network of 
cytokines that lead to the progressive destruction 
of the tooth supporting tissues and ends with 
tooth loss.1,2 Diabetes mellitus (DM) and chronic 
periodontitis are chronic disorders previously 
known to be biologically linked, with 
inflammation being the main feature of their 
pathogenesis.3,4 Diabetes is considered an 
important risk factor for periodontitis, thereby 
influencing the osteoclasts and osteoblasts of the 
periodontium through several routes, such as by 
the over expression of inflammatory mediators 
and by increasing the receptor activator of 
nuclear factor kappa-Β ligand (RANKL) / 
osteoprotegerin (OPG) ratio, advanced 
glycated end-products (AGEs), and reactive 
oxygen species (ROS) levels.4 OPG is structurally 
similar to receptor activator of nuclear factor 
kappa-Β (RANK) and is therefore a soluble 
decoy receptor for RANKL. It is also called 
"bone protector" and is produced by many cells 
including osteoclasts. As RANKL binds to OPG 
instead of its original receptor RANK, the 
differentiation of osteoclasts is prevented 
leading to a subsequent decrease in bone loss.5   
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The RANKL/OPG ratio plays an important role 
in bone homeostasis where an increase in the 
RANKL/OPG ratio, occurring either by increased 
RANKL or decreased OPG, will increase bone 
loss and vice versa. In active sites of periodontal 
disease, the RANKL/OPG ratio was found to be 
increased correlating with disease activity.6,7 
The interleukin (IL)-1 family of cytokines 
plays a major role in stimulation and regulation 
of immune and inflammatory processes.2 A newly 
discovered member of the IL-1 family is IL-33, 
also known as IL-1F11, which is expressed on 
various cells including activated macrophages, 
fibroblasts, epithelial cells, keratinocytes, 
endothelial cells, and dendritic cells. IL-33 serves 
as the ligand of the ST2 receptor which is a 
member of the Toll-like receptor/IL-1R 
superfamily. Also, IL-33 activates many cells 
including T-helper2 (Th2) cells, mast cells, 
basophils and eosinophils.8 
IL-33 has a dual function by acting 
intracellularly as an anti-inflammatory cytokine 
and extracellularly as a proinflammatory 
cytokine. It stimulates the production of IL-4, IL-5, 
and IL-13 through Th2 cells, and also triggers 
the secretion of tumor necrosis factor-α (TNF-α), 
IL-6, and IL-1β which are proinflammatory 
mediators.1,8 
IL-33 released by damaged cells acts as 
an alarm, especially in endothelial or epithelial 
cells exposed directly to environmental factors. 
Moreover, the survival, maturation, and adhesion 
of mast cells are facilitated by IL-33, which in 
turn recognize IL-33 and become activated to 
secrete histamine, leukotrienes, prostanoids, 
proteases, cytokines, and chemokines, thus 
recruiting neutrophils to the infection site and 
stimulating an inflammatory response. This 
suggests that the produced inflammatory 
mediators and IL-33 cause osteoclast activation 
by increasing RANKL expression and decreasing 
OPG production. Thus, IL-33 may have a role in 
alveolar bone destruction in periodontitis.9,10 IL-
33 was previously studied with chronic 
periodontitis in GCF, saliva, and serum.8,11 
An ongoing relation exists between 
diabetes and chronic periodontitis, with the latter 
being the sixth complication of diabetes and is 
considered a risk factor.3 Concurrently, there is 
an increased risk of severity of periodontal 
disease in diabetic patients due to 
hyperglycemia, leading to an exaggerated 
inflammatory immune response.4   
Consequently, this study investigates the 
effect of type 2 DM on chronic periodontitis by 
detecting the levels of IL-33 and OPG in 
gingival crevicular fluid (GCF) and saliva, which 
seem to have opposite roles in periodontal 
inflammation. 
Materials and Methods  
This study included a total of 60 subjects of the 
Egyptian population that were categorized into 
20 patients presenting with chronic periodontitis 
(CP) (group I) according to the Armitage et al. 
1999  classification,11 20 patients presenting 
with chronic periodontitis along with type 2 
diabetes mellitus (CP-DM) (group II), and 20 
systemically and periodontally healthy control 
subjects (group III). The study groups can be 
elaborated as follows: 
Group I: CP which was comprised of 13 females 
and 7 males ranging between the ages of 32 
and 48 years (mean of 38.2 ±4.5) 
Group II: CP-DM which was comprised of 13 
females and 7 males ranging between the ages 
of 20 and 41years (mean of 28.9 ± 6.3) 
Group III: Control group which was comprised of 
14 females and 6 males (mean age 34.9±6.6) 
who had PD < 3 mm and no CAL, clinical 
inflammation, or bone loss 
 The protocol was approved by the Cairo 
University Research Ethics Committee, and their 
outpatient clinic was used for patient selection. 
Informed consent was obtained from the subjects 
prior to inclusion in the study. Complete records 
of the periodontal examination, diagnosis, 
treatment, and recommended follow-up were 
maintained. 
 Diabetic patients were recruited 
according to the American Diabetes 
Association12 defining type 2 diabetes as 
untreated adult-onset hyperglycemia with a 
glycated hemoglobin (HbA1c) level of ⩾6.5% 
and normoglycemia defined as HbA1c of ⩽ 6%. 
Exclusion criteria included any other systemic 
disease, pregnancy, antibiotic therapy, and 
long-term use of drugs that can cause gingival 
changes. 
Clinical Parameters 
Clinical parameters were recorded for six sites 
per tooth (mesiobuccal, buccal, distobuccal, 
distolingual, lingual, and mesiolingual) for the 
whole dentition except for the third molars if 
present. Parameters were recorded using 
William's periodontal probe and they included:   
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(a) gingival idex,13 (b) plaque index,14 (c) 
probing depth (PD),15 and (d) clinical attachment 
loss (CAL).16 The inclusion criteria for chronic 
periodontitis patients was based on a clinical 
examination demonstrating the involvement of 
>30% of sites with a CAL ≥ 5mm, and a PD 
>6mm. Treatment of patients was commenced on 
the following visit, after recording the clinical 
parameters, collecting the samples, and 
delivering oral hygiene instructions in the first 
appointment. 
GCF Sample Collection  
Upon removal of supragingival plaque, the 
required areas were isolated using cotton rolls 
after being washed with a water spray and 
dried with an air syringe. GCF was obtained 
using filter paper strips, which were inserted into 
the pocket or sulcus with the greatest depth until 
a slight resistance was felt and were left in 
place for 30 seconds. The strips were placed 
into sterile Eppendorf tubes. Paper strips 
contaminated with blood were excluded. All 
GCF samples were immediately stored at −80˚C 
until subsequent analysis. 
Salivary Sample Collection 
Whole unstimulated saliva was collected using 
standard techniques as described by 
Navazesh.17 Subjects refrained from eating, 
drinking, chewing gum etc., for at least half an 
hour prior to the evaluation. Samples were 
collected by asking subjects to swallow first, tilt 
their head forward and expectorate saliva in a 
tube for five minutes without swallowing. 
Following collection, all samples were 
immediately stored at -80˚C until assayed. 
Quantitation of IL-33 
Quantitative measurements of human IL-33 
concentrations were determined using a Human 
IL-33 ELISA Kit.a This assay employs the 
quantitative sandwich enzyme immunoassay 
technique. A polyclonal antibody specific for IL-
33 was pre-coated onto a microplate. 
Standards and samples were pipetted into the 
wells causing any IL-33 present to be bound by 
the immobilized antibody. After washing away 
any unbound substances, an enzyme-linked 
polyclonal antibody specific for IL-33 was 
added to the wells. Following a wash to remove 
any unbound antibody-enzyme reagent, a 
substrate solution was added to the wells and 
observed for color changes which would be 
                                                          
a Quantikine, R&D Systems, Inc. Minneapolis, USA, 
and Catalog Number D3300 
proportional to the amount of IL-33 bound in the 
initial step. Once the color development 
stopped, the intensity of the color was measured. 
Quantitation of Osteoprotegerin 
OPG was quantified using a Human 
Osteoprotegerin Instant ELISA Kit.b An anti-
human OPG polyclonal coating antibody was 
adsorbed onto microwells. Human OPG present 
in the sample or standard would then bind to 
antibodies adsorbed onto the microwells, and a 
biotin-conjugated polyclonal anti-human OPG 
antibody would bind to human osteoprotegerin 
captured by the first antibody. Streptavidin-HRP 
would then bind to the biotin conjugated anti-
human OPG. Following incubation, unbound 
biotin conjugated anti-human OPG and 
Streptavidin-HRP were removed during a wash 
step, and a substrate solution reactive with HRP 
was added to the wells. The formed colored 
product would be proportional to the amount of 
soluble human OPG present in the sample. The 
reaction was then terminated through the 
addition of an acid, and absorbance was 
measured at 450 nm. A standard curve was 
prepared using seven human OPG standard 
dilutions and the human OPG sample 
concentration was determined. 
Statistical Analysis  
Numerical data were explored for normality by 
checking the distribution of data and using tests 
of normality (Kolmogorov-Smirnov and Shapiro-
Wilk tests). Age data showed normal 
(parametric) distribution while all other variables 
showed non-normal (non-parametric) distribution. 
Parametric data were presented as mean, 
standard deviation (SD), and 95% Confidence 
Interval (95% CI) values. Non-parametric data 
were presented as median, Inter-Quartile Range 
(IQR), mean, and standard deviation (SD) values.  
For parametric data, one-way ANOVA 
was used to compare between the three groups. 
Bonferroni’s post-hoc test was used for pair-wise 
comparisons when ANOVA test was significant. 
As for non-parametric data, Mann-Whitney U 
test was used for comparisons between the two 
experimental groups. Kruskal-Wallis test was 
used to compare between the three groups. 
Dunn’s test was used for pair-wise comparisons. 
Spearman’s correlation coefficient was used to 
determine significant correlations between 
markers and different variables.  
                                                          
b BMS2021INST provided by eBioscience (Bender 
MedSystem GmbH, Vienna, Austria)  
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Qualitative data were presented as 
frequencies and percentages. Chi-square test 
was used for the comparisons. 
Receiver operating characteristic (ROC) 
curve was constructed to determine the cut-off 
values of different markers for differentiation 
between the three groups. Areas under the ROC 
curve (AUCs) were compared using z-statistic. 
The significance level was set at P ≤ 
0.05. Statistical analysis was performed using 
IBM SPSS Statistics Version 20 for Windows. 
ROC curve analysis was performed using 
MedCalc Version 11.3 for Windows (MedCalc 
Software bvba).  
Sample Size Calculation  
The power analysis was for one-way 
fixed effect Analysis of Variance (ANOVA) for 
comparison between the three groups. 
Calculation utilized IL-33 level as the primary    
outcome based upon the results of Saĝlam et al. 
(2017). The effect size (f) was 24.3, using alpha 
(α) level of 0.05 (5%) and Beta (β) level of 0.10 
(10%) i.e. power = 90%; the minimum estimated 
sample size was a total of 18 subjects (6 
subjects per group). Oversampling was 
employed for the sake of reliable results. 
Sample size was calculated using IBM SPSS 
SamplePower (IBM® Corporation, NY, USA. 
SPSS®, Inc., an IBM Company), Release 3.0.1.  
Results  
 There was no statistically significant 
difference between gender distributions in the 
three groups.  
 As regards to age, there was no 
statistically significant difference between the 
CP and control group; both showed significantly 
higher mean age values than the CP-DM group. 
Figure 1. ROC curves of markers for 
differentiation between the CP and control 
groups 
 
Figure 2. ROC curves of markers for 
differentiation between the CP and the CP-DM 
groups 
 
 The CP group showed a significantly 
higher median PI and GI than the CP-DM group. 
There was no statistically significant difference 
between the median PD for the two groups. The 
CP group showed a significantly lower median 
CAL than the CP-DM group. 
 Regarding OPG concentrations in GCF 
and saliva, the control group showed a 
significantly higher mean level than the other 
groups; there was no statistically significant 
difference between the CP and CP-DM groups.  
As for IL-33 concentrations in GCF, there 
was no statistically significant difference 
between the CP and CP-DM groups; both 
showed a significantly higher mean IL-33 level 
than the control group.  
Regarding IL-33 levels in saliva, the CP-
DM group showed a significantly higher mean 
level than the other groups. The CP group 
showed a significantly lower mean value, and 
the control group showed the lowest mean level, 
which was of statistical significance (Table 1). 
The ROC curve analysis of the markers 
for differentiation between the CP and control 
subjects showed cut-off values of 101, 70, 13.9 
and 16.8 pg/ml for OPG in GCF, OPG in 
saliva, IL-33 in GCF, and IL-33 in saliva, 
respectively. OPG in GCF and saliva showed the 
highest diagnostic accuracy (100% for each 
marker). IL-33 in GCF showed a lower 
diagnostic accuracy of 94.4%, and IL-33 in 
saliva showed the lowest diagnostic accuracy of 
83.3%. Pair-wise comparison of the AUCs for 
the markers showed a statistically insignificant 
difference (Table 2; Figure 1). 
The ROC curve analysis of the markers 
for differentiation between CP-DM and control 
subjects showed cut-off values of 123, 77, 13.9 
and 16.8 pg/ml for OPG in GCF, OPG in 
saliva, IL-33 in GCF, and IL-33 in saliva,  
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Table 1. Descriptive statistics and results of Kruskal-Wallis test for comparisons between markers’ levels 
in the three groups 
*: Significant at P ≤ 0.05; Different superscripts in the same row are significantly different 
 
Table 2. Cut-off values for different markers and the corresponding sensitivity, specificity, predictive 
values, diagnostic accuracy, area under the ROC curve (AUC), and 95% confidence interval (95% CI) of 
the (AUC) for differentiation between the CP and control groups 
+PV: Positive predictive value; -PV: Negative predictive value; AUC: Area under the curve; CI: Confidence interval 
 
respectively. All markers showed 100% 
diagnostic accuracy. 
The ROC curve analysis of the markers 
for differentiation between the CP and CP-DM 
groups showed cut-off values of 61, 63, 23, and 
25.6 pg/ml for OPG in GCF, OPG in saliva, IL-
33 in GCF, and IL-33 in saliva, respectively. IL-
33 in saliva showed the highest diagnostic 
accuracy (82.5%). IL-33 in GCF showed a lower 
diagnostic accuracy of 75%, followed by OPG 
in saliva at 67.5%. OPG in GCF showed the 
lowest diagnostic accuracy at 62.5%. Pair-wise 
comparison of the AUCs for the markers 
demonstrated that IL-33 in saliva had a 
significantly higher mean AUC than OPG in GCF 
and OPG in saliva (Table 3; Figure 2). 
  
There was a statistically significant, 
direct, positive correlation between OPG in GCF 
and OPG in saliva, i.e. an increase in OPG in 
GCF is associated with an increase in OPG in 
saliva and vice versa. There was also a 
significant, inverse, negative correlation between 
OPG in GCF and IL-33 in GCF and saliva, i.e. 
an increase in OPG in GCF is associated with a 
decrease in IL-33 in GCF and saliva and vice 
versa. There was no significant correlation 
between OPG in GCF and other variables 
(Table 4). 
The results demonstrated a statistically 
significant, inverse, negative correlation between 
OPG in saliva and PI, i.e. an increase in PI is 
associated with a decrease in OPG in saliva and   
 
CP 
(n = 20) 
CP-DM 
(n = 20) 
Control 
(n = 20) 
P-value 
OPG in GCF (pg/ml)     
Median (IQR) 
66.5 (60 – 71.5) 
B 
69 (65.3 – 78.3) 
B 
219.5 (185.3 – 233) 
A <0.001* 
Mean (SD) 67.7 (11.4) 74.4 (16.2) 212.4 (41.1) 
OPG in Saliva(pg/ml)     
Median (IQR) 
59 (53 – 64.5) 
B 
65.5 (59.3 – 69) 
B 
134 (120.3 – 150.8) 
A <0.001* 
Mean (SD) 58.4 (7.0) 64.5 (6.5) 134.7 (18.1) 
IL-33 in GCF (pg/ml)    
<0.001* Median (IQR) 
22.8 (17.4 – 30.2) 
A 
30.5 (27 – 36.8) 
A 
10.8 (10 – 11.6) 
B 
Mean (SD) 25.1 (10.1) 31.9 (6.5) 10.9 (1.4) 
IL-33 in Saliva (pg/ml)    
<0.001* Median (IQR) 
20.4 (15.8 – 25.1) 
B 
32.5 (27 – 40) 
A 
12.4 (11.2 – 15) 
C 
Mean (SD) 20.7 (6.1) 33.1 (7.5) 12.9 (2.3) 
Marker 
Cut-
off 
Sensitivity 
% 
Specificity 
% 
+PV 
% 
-PV 
% 
Diagnostic 
Accuracy % 
AUC 95% CI 
OPG in 
GCF 
101 100 100 100 100 100 1.000 
0.903 – 
1.000 
OPG in 
Saliva 
70 100 100 100 100 100 1.000 
0.903 – 
1.000 
IL-33 in 
GCF 
13.9 90 100 100 88.9 94.4 0.966 
0.844 – 
0.998 
IL-33 in 
Saliva 
16.8 70 100 100 72.7 83.3 0.903 
0.758 – 
0.976 
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vice versa. There was a significant, inverse, 
negative correlation between OPG in saliva and 
CAL, i.e. an increase in CAL is associated with a 
decrease in OPG in saliva and vice versa. There 
was also a significant, inverse, negative 
correlation between OPG in saliva and IL-33 in 
GCF and saliva i.e. an increase in OPG in saliva 
is associated with a decrease in IL-33 in GCF 
and saliva. There was no significant correlation 
between OPG in saliva and other variables. 
 
Table 3. Cut-off values for different markers and the corresponding sensitivity, specificity, predictive 
values, diagnostic accuracy, area under the ROC curve (AUC), and 95% confidence interval (95% CI) of 
the (AUC) for differentiation between the CP and CP-DM groups 
+PV: Positive predictive value; -PV: Negative predictive value; AUC: Area under the curve; CI: Confidence interval 
 
Furthermore, a statistically significant, 
direct, positive correlation was observed 
between IL-33 in GCF and both PI and GI i.e. an 
increase in PI and GI is associated with an 
increase in IL-33 in GCF and vice versa. 
Comparing IL-33 in GCF and both PD and CAL, 
a significant, direct, positive correlation was 
observed, i.e. an increase in PD and CAL is 
associated with an increase in IL-33 in GCF and 
vice versa. A significant, direct, positive 
correlation was also found between IL-33 in 
GCF and IL-33 in saliva, i.e. an increase in IL-33 
in GCF is associated with an increase in IL-33 in 
saliva and vice versa.  
A statistically significant, direct, positive 
correlation between IL-33 in saliva and PI was 
demonstrated i.e. an increase in PI is associated 
with an increase in IL-33 in saliva and vice versa. 
As for IL-33 in saliva and CAL, a significant, 
direct, positive correlation was observed i.e. an 
increase in CAL is associated with an increase in 
IL-33 in saliva and vice versa. No significant 
correlation was found between IL-33 in saliva 
and other variables. 
 
Discussion 
The relationship between periodontitis and 
systemic diseases such as cardiovascular 
disorders and DM has been previously 
described.18 Previous research stated that 
uncontrolled diabetic conditions exhibit a more 
severe breakdown of the periodontium via 
vascular changes such as gingival 
microangiopathy and increased serum 
proinflammatory cytokines that alter periodontal 
tissue response and delay wound healing.19 By 
preventing osteoclast differentiation, OPG 
functions as a natural inhibitor of alveolar bone 
destruction by acting as a decoy receptor for 
RANKL, thus inhibiting its binding to RANK.20 
 Interleukin-33 plays an important role in 
the immune response for diseases such as 
rheumatoid arthritis, asthma, cardiovascular 
disease, and diabetes. It activates nuclear factor 
kappa-B (NF-ĸB) via its receptor ST2 present on 
mast cells and Th2-cells, and it has been recently 
linked to periodontitis due to its stimulation of 
RANKL.21 
 In the present study, IL-33 levels in both 
GCF and saliva were found to be higher in the 
CP and CP-DM groups compared to the healthy 
control, indicating and highlighting the role of IL-
33 in the inflammatory process that takes place 
in periodontitis. Moreover, the results 
demonstrated that IL-33 levels in the GCF and 
saliva of the CP-DM group was higher than that 
of the CP group, marking the adverse effect of 
diabetes on periodontal disease. In 2014, 
Casanova et al22 stated that periodontal 
disease was found to affect levels of HbA1c in 
non-diabetic patients. They also stated that a 
number of studies proved that periodontal 
treatment acts as a positive factor in controlling 
hyperglycemia in diabetic patients. 
Marker 
Cut-
off 
Sensitivity 
% 
Specificity 
% 
+PV 
% 
-PV 
% 
Diagnostic 
Accuracy % 
AUC 95% CI 
OPG in 
GCF 
61 90 35 58.1 77.8 62.5 0.631 
0.464 – 
0.778 
OPG in 
saliva 
63 60 75 70.6 65.2 67.5 0.738 
0.575 – 
0.864 
IL-33 in 
GCF 
23 95 55 67.9 91.7 75 0.740 
0.577 – 
0.866 
IL-33 in 
saliva 
25.6 80 85 84.2 81 82.5 0.900 
0.763 – 
0.972 
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Table 4. Results of Spearman's correlation coefficient for different variables 
*: Significant at P ≤ 0.05 
The results of the present study were partially in 
accordance with that of the study carried out by 
Saglam et al.,8 who found that the total amount 
of IL-33 in GCF was greater in gingivitis and 
chronic periodontitis compared to healthy control 
subjects. Unlike the present study however, 
salivary IL-33 levels were similar for all groups. 
 The results concerning IL-33 levels in GCF 
were in contrast to what was documented in the 
study carried out by Kursunlu et al.,2 who stated 
that there was no statistical significance between 
chronic periodontitis patients and healthy 
subjects regarding IL-33 in GCF. The results 
were also in contrast to Papathanasiou et al.,1 
who failed to detect IL-33 in the GCF of patients 
with chronic periodontitis. Moreover, although 
Buduneli et al.3 detected IL-33 in chronic 
periodontitis patients and the healthy controls, 
they concluded that chronic periodontitis and a 
clinically healthy periodontium could not be 
differentiated based on IL-33 level. This contrast 
may be due to different populations, levels of 
tissue destruction and gingival inflammation, 
different kits used to register IL-33 
concentrations, utilization of different techniques, 
or different sample sizes.  
 As for OPG, the results of the present 
study demonstrated significantly higher levels in 
the GCF and saliva of the control group 
compared to the CP and CP-DM groups. This 
may reflect the destruction of alveolar bone 
taking place in periodontal disease in the 
absence of the protective role of OPG, thus 
stressing its effect on the inhibition of osteoclast 
differentiation. The OPG results were similar to 
those found in the study performed by Ochanji 
et al.5 who measured OPG levels in saliva only 
and found that the RANKL/OPG ratio was 
positively correlated with the severity of 
periodontitis. Regarding OPG in GCF, similar 
findings were reported by Mogi et al.23 who 
stated that the mean OPG value was 
significantly lower in patients with periodontitis 
compared to controls.  
 On comparing the diagnostic accuracy of 
OPG and IL-33 in GCF and saliva of the CP and 
control groups, all were above the cut off value, 
but OPG had the highest diagnostic accuracy at 
100%, while IL-33 demonstrated lower 
diagnostic accuracy in GCF followed by saliva. 
This indicates that OPG as a marker is more 
accurate, whereby it increases in a state of 
health in both GCF and saliva. Additionally, on 
comparing the CP-DM and control groups, all 
markers demonstrated 100% accuracy, thus 
supporting the use of OPG as a biological 
marker, which exhibited higher levels in the 
healthy state compared to the diseased state, 
and IL-33, for which higher levels were recorded 
in the diseased state compared to the healthy 
state. As for the diagnostic accuracy of OPG 
and IL-33 in the CP and CP-DM groups, IL-33 in 
saliva demonstrated the highest diagnostic 
accuracy. These data help in distinguishing the 
validity of the use of these biological markers 
for the conditions presented in this study. We 
are unaware of any other studies that utilize the 
ROC curve in investigating the diagnostic 
Variables 
OPG in GCF OPG in Saliva IL-33 in GCF IL-33 in Saliva 
Correlation 
Coefficient 
P-value 
Correlation 
Coefficient 
P-value 
Correlation 
Coefficient 
P-value 
Correlation 
Coefficient 
P-value 
Age 0.007 0.958 -0.070 0.607 -0.149 0.273 -0.184 0.175 
PI -0.099 0.543 -0.439 0.005* 0.324 0.041* 0.366 0.025* 
GI -0.094 0.562 -0.134 0.411 0.385 0.014* -0.218 0.177 
PD 0.135 0.407 0.296 0.064 0.404 0.010* 0.307 0.054 
CAL 0.274 0.087 -0.345 0.029* 0.347 0.028* 0.416 0.008* 
OPG in 
GCF 
- - 0.621 <0.001* -0.583 <0.001* -0.468 <0.001* 
OPG in 
Saliva 
0.621 <0.001* - - -0.500 <0.001* -0.357 0.007* 
IL-33 in 
GCF 
-0.583 <0.00* -0.500 <0.00* - - 0.651 <0.001* 
IL-33 in 
Saliva 
-0.468 <0.001* -0.357 0.007* 0.651 <0.001* - - 
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accuracy of IL-33 and OPG when used 
biological markers. 
 As for the correlation of the clinical 
parameters with our markers, the results 
demonstrated a positive correlation between IL-
33, in both GCF and saliva, and PI and CAL, 
while a negative correlation was found between 
IL-33, in both GCF and saliva, and OPG, in both 
GCF and saliva. Furthermore, a negative 
correlation was determined between OPG in 
saliva and PI and CAL, while a positive one was 
found between OPG in saliva and OPG in GCF. 
These findings indicate that both OPG and IL-33 
correlate well with clinical parameters. 
Moreover, they demonstrate that saliva could be 
of equal importance compared to GCF in the 
detection of biomarkers of periodontal disease, 
and possibly a superior tool that is characterized 
by easier and less time-consuming collection that 
does not require special equipment or trained 
personnel. 
 The previously mentioned data 
concerning IL-33 and OPG serve as evidence 
regarding their significant role in periodontal 
disease pathogenesis, and the influence of 
diabetes on periodontitis reflected through their 
expression. This signifies their possible utilization 
in either GCF or saliva for the diagnosis and 
differentiation of periodontal disease. 
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